PPT-Tri-leaflet Aortic Valve

Aortic Stenosis Nishimura RA et al 2014 AHAACC Valvular Heart Disease Guideline Nishimura RA et al 2014 AHAACC Valvular Heart Disease Guideline Table 8 2014 AHAACC Stages of Valvular AS. Kunjan Bhatt MD. Austin Heart. Let’s . Start off with some questions!. Question 1. Components for the continuity equation for AVA include all the following except? . 1. MV annular diameter. 2. MV annular VTI. Allan Stewart, MD., Jonathan A. Yang, MD; Mark J. Russo, MD/MPH; Alexander . Iribarne. , MD; Brendan F. Scully; Rachel . Easterwood. ; Craig R. Smith, MD; Division of Cardiothoracic Surgery, Columbia University Medical Center, New York, NY. Dr. Snehal Kulkarni. Division of Pediatric Cardiology. Kokilaben. . Ambani. Hospital, Mumbai. Aortic valve stenosis. Morphologically diverse condition. Varies in severity. Asymptomatic to critically ill. Causes of valve regurgitation. congenital, senile degeneration, acute and chronic rheumatic . carditis. , infective . endocarditis. , syphilitic . aortitis. traumatic valve rupture, damage to . chordae. EZiOPATOLOGIA. DELLE VALVULOPATIE AORTICHE. G. Caruso. anatomia patologica. . Universita. ‘ di Bari. Heartline. IRCCS S. Martino. Genova. Cardiology. meeting. 14-15 novembre 2014. MALATTIE VALVOLARI . Supported by:. Medtronic inc. Bard Inc. Terumo Medical Corp. Disclosures. Samin K. Sharma, MD, FACC. . Speaker’s Bureau – Boston Scientific Corp., Abbott Vascular Inc, ABIOMED, CSI. Annapoorna S. Kini, MD, FACC. Dominik Fleischmann. Department of Radiology. Stanford University. 20. th. Annual Summer Practicum, Masters in Body Imaging. Jackson Lake Lodge, Moran, Wyoming. August 8-11, 2010. . Research support: General Electric. Therapy and Maximising TAVI Programme Leveraging unique advantages of a TAVI portfolio for optimised outcomes and early discharge cardiovascularnews.com This educational supplement has been spo introduction. Between 300,000 and 400,000 surgical valve replacements are performed annually worldwide.. Aortic valve replacement accounts for the majority of surgical interventions, followed by mitral and tricuspid valve replacement.. TAVR in Low-Risk Bicuspid in Patients. John Forrest, MD. Associate Professor of Medicine. Director of Interventional Cardiology and Structural Heart Program. Yale University School of Medicine. Yale Health System. System. Designed. . by. . Khalil. . Fattouch. , MD, . PhD. .. University. . of. Palermo. Cardiac. . Surgery. . Department. Aortic. valve . What. . we. . learn. . from. the . mitral. valve? . Shinichi Fukuhara, MD . (. 1,4,5). , Stephane Leung, MD (2,4,5), Daizo Tanaka, MD (3,4), Devraj Sukul, MD (1,5), P. . . Michael Grossman, MD (1,5), Stanley J. Chetcuti, MD (1,5), Chang He, PhD (4,5), Melissa Clark, MSN (4,5), Himanshu J. Patel, MD (1,4,5). John . Bryfogle. Professor of Cardiovascular Medicine and Surgery. Health System Director for Interventional Cardiology. Director, Cardiac Cath Labs, Hospital of the Univ of PA. Perelman School of Medicine . Gregory Condos, MD, LCDR, MC, USN; Katherine Rees; Rasleen Grewal; Hirsch Mehta, MD; Raghava Gollapudi, MD; Karl Limmer, MD; Arvin Narula, MD. Disclosures. The authors have no relevant financial disclosures..